Novartis' Agriflu seasonal influenza vaccine approved in US
by Poonam Singhal

The U.S. Food and Drug Administration approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.
Agriflu, manufactured by Novartis Vaccines and Diagnostics in Siena, Italy, was approved using the FDA's accelerated approval pathway, which helps safe and effective medical products for serious or life-threatening diseases become available sooner.
In this case, Novartis demonstrated that the vaccine induced levels of antibodies in the blood likely to be effective in preventing seasonal influenza.
Agriflu is administered as a single injection in the upper arm and is available in single dose, pre-filled syringes that do not contain preservatives.
"The approval of the new seasonal influenza vaccine, Agriflu, is an important step in adding to the production capacity to enhance the supply of vaccine for the United States for future influenza seasons," said Karen Midthun, M.D., acting director of the FDA's Center for Biologics Evaluation and Research.
Common side effects in clinical studies included pain, swelling and redness at the injection site, headache, muscle aches and malaise. People with severe or life-threatening allergies to chicken eggs, or to any other substance in the vaccine, should not be vaccinated.
As part of the accelerated approval process, Novartis is required to conduct further studies to verify that the vaccine induces levels of antibodies in the blood that are effective in preventing seasonal influenza. The company also manufactures another licensed seasonal influenza vaccine, Fluvirin, for use in the United States. Fluvirinis approved for people ages 4 years and older. Agriflu is not intended to protect against the 2009 H1N1 influenza.
(Poonam Singhal -- sub-editor compiled and published
Novartis' Agriflu seasonal influenza vaccine approved in US at HealthNewsTrack on November 29, 2009 sourced from U.S. Food and Drug Administration - http://www.fda.gov/)
Influenza - recent articles and current news stories:
-
Cholesterol lowering drugs statins may help hospitalized influenza patients-
New GM-SCF therapy to defeating flu shows promise-
Universal influenza vaccine possible in future-
H1N1 influenza severity linked to Streptococcus pneumoniae-
Human protein may prevent H1N1 influenza infectionInfluenza article/news source:
Read more health articles from
U.S. Food and Drug Administration and
health articles from USA.
Influenza - search related terms:
Influenza,
Influenza season,
Influenza vaccine,
Influenza virus,
Seasonal influenza,
Seasonal influenza vaccine,
Influenza books,
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
Subscribe to Health News by Email
Current news
FDA Approves Agriflu Seasonal Influenza Vaccine -- Another option to prevent illnesses caused by subtypes A and B influenza virus
About InfluenzaInfluenza, commonly known as the flu, is an infectious disease of birds and mammals caused by an RNA virus of the family Orthomyxoviridae, the influenza viruses. In people, common symptoms of influenza are fever, sore throat, muscle pains, severe headache, coughing, and weakness and fatigue.